Free Republic
Browse · Search
Topics · Post Article

Skip to comments.

Protein discovery could help solve prostate cancer drug resistance (“Dramatic” effect from $10 a month drug (dicyclomine))
Medical Xpress / Washington State University / Cell Reports Medicine ^ | Jan. 22, 2024 | Boyang (Jason) Wu et al

Posted on 01/28/2024 8:45:23 PM PST by ConservativeMind

Researchers have identified a receptor protein known as CHRM1 as a key player in prostate cancer cells' resistance to docetaxel, a commonly-used chemotherapy drug to treat advanced cancer that has spread beyond the prostate.

The discovery opens the door to new treatment strategies that could overcome this resistance.

The study showed that blocking CHRM1 in resistant prostate cancer cell lines and an animal model based on patient-derived resistant tissue restored docetaxel's ability to kill cells and stop tumor growth. The researchers did this by using dicyclomine, a drug that selectively inhibits CHRM1 activity. Dicyclomine is already on the market as a generic drug and is currently used to treat symptoms of irritable bowel syndrome.

"The effect was pretty dramatic in all the experimental models we tested," said Boyang (Jason) Wu.

Docetaxel resistance can develop in prostate cancer after about six months of treatment. Chemotherapy drugs like docetaxel are among very few options available to patients with castration-resistant prostate cancer, a lethal form of the disease that no longer responds to hormone therapy.

Wu said this type of combination therapy could also potentially be used for other cancers treated with docetaxel, such as breast and lung cancer. It may also be possible to use the same combination strategy with other similar chemotherapy drugs.

In addition to testing resistant cancer cell lines, the research team also tested cells that still responded to docetaxel treatment. They found that using dicyclomine to block CHRM1 in these cells made docetaxel more efficient at killing them. Wu said that prostate cancer patients could potentially benefit from a combination treatment strategy even before docetaxel resistance develops.

"What this suggests is that the lowest effective dose of docetaxel may be lower when the drug is combined with dicyclomine, compared to when docetaxel is used alone," Wu said.

(Excerpt) Read more at ...

TOPICS: Health/Medicine
KEYWORDS: cancer; chemotherapy; chrm1; dicyclomine; docetaxel; prostate; protein; resistance; treatment
Castration-resistant prostate cancer treatment (and possibly that of other cancers) can be greatly enhanced and made effective again through docetaxel, with a $10 drug, dicyclomine.
1 posted on 01/28/2024 8:45:23 PM PST by ConservativeMind
[ Post Reply | Private Reply | View Replies]

To: Mazey; ckilmer; goodnesswins; Jane Long; BusterDog; jy8z; ProtectOurFreedom; matthew fuller; ...

The “Take Charge Of Your Health” Ping List

This high volume ping list is for health articles and studies which describe something you or your doctor, when informed, may be able to immediately implement for your benefit.

Email me to get on either the “Common/Top Issues” (20 - 25% fewer pings) or “Everything” list.

2 posted on 01/28/2024 8:46:04 PM PST by ConservativeMind (Trump: Befuddling Democrats, Republicans, and the Media for the benefit of the US and all mankind.)
[ Post Reply | Private Reply | To 1 | View Replies]

To: ConservativeMind


3 posted on 01/28/2024 8:58:06 PM PST by linMcHlp
[ Post Reply | Private Reply | To 1 | View Replies]

Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.

Free Republic
Browse · Search
Topics · Post Article

FreeRepublic, LLC, PO BOX 9771, FRESNO, CA 93794 is powered by software copyright 2000-2008 John Robinson